Could a common nerve drug replace carpal tunnel surgery?

NCT ID NCT06294821

Not yet recruiting Symptom relief Sponsor: John Elfar Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether 4-aminopyridine, a drug already approved for other nerve conditions, can improve symptoms of carpal tunnel syndrome or delay the need for surgery. Researchers will give 160 adults either the drug or a placebo for 6 weeks and track symptom changes using hand function questionnaires. The goal is to see if this medication can be a non-surgical treatment option.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 4-aminopyridine
What this could lead to: If it works, this could offer a non-surgical option to relieve carpal tunnel symptoms and postpone or avoid the need for surgery.
What could go wrong: This is an early phase 2 trial with only 160 participants. The drug may not improve symptoms better than placebo, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARPAL TUNNEL SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carpal tunnel syndrome hereditary neuropathy with liability to pressure palsies nerve compression syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARPAL TUNNEL SYNDROME COMPRESSION NEUROPATHY

More trials for these conditions

Other studies related to the condition(s) this trial covers.